Patients as Partners London Feb 2017 presentation by Jan Geissler and myself. The rational behind PFMD.org and our journey building a systematic approach to patient involvement.
everyLIFE Technologies - Big Innovation ConversationInnovation Agency
Presentation by Taffy Gatawa, Chief Information and Compliance Officer, everyLIFE Technologies at the System Flow Big Innovation Conversation webinar on Thursday 9 May.
everyLIFE Technologies - Big Innovation ConversationInnovation Agency
Presentation by Taffy Gatawa, Chief Information and Compliance Officer, everyLIFE Technologies at the System Flow Big Innovation Conversation webinar on Thursday 9 May.
The 5Q approach is simple, adaptable, responsive, effective, and better integrates stakeholders.Project beneficiaries can proactively participate in programs for greater livelihood, health, and environmental gains.
HPE Fortify OnDemand Helps VerticalRent Achieve E13PA Compliance Matt Angerer
ResultsPositive Inc., a Platinum HPE Partner, leveraged HPE Fortify OnDemand to help the nation's leading online rental property and tenant screening platform achieve E13PA and PCI-DSS compliance. This case study showcases the opportunity and how the ResultsPositive team can help your organization protect application and achieve compliance.
Presentation on 'Effective partnerships: An example in water capacity development' by Kees Leendertse, Cap-Net at 2014 UN-Water Annual International Zaragoza Conference. Preparing for World Water Day 2014: Partnerships for improving water and energy access, efficiency and sustainability. 13-16 January 2014
This is a presentation made at the Asian eHealth Professionals Network by Rajendra Pratap Gupta on the Innovation Working Group Asia which he co-chairs.
Steve Haggblade
POLICY SEMINAR
What Drives Policy Change? Insights from the Kaleidoscope Model of Food Security Policy
Organized by IFPRI, Michigan State University and University of Pretoria, Consortium partners- Food Security Policy Innovation Lab
Slides used for UKGovCamp '14 - to stimulate debate around experiences of using different digital tools to engage (inform, consult and collaborate) with stakeholders
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...patvocates
Patient Advocates in Cancer Research: European Patients’ Perspective, presented by Jan Geissler (Twitter @jangeissler) at ISOQOL 19th Annual Conference, Budapast, 26 Oct 2012
The 5Q approach is simple, adaptable, responsive, effective, and better integrates stakeholders.Project beneficiaries can proactively participate in programs for greater livelihood, health, and environmental gains.
HPE Fortify OnDemand Helps VerticalRent Achieve E13PA Compliance Matt Angerer
ResultsPositive Inc., a Platinum HPE Partner, leveraged HPE Fortify OnDemand to help the nation's leading online rental property and tenant screening platform achieve E13PA and PCI-DSS compliance. This case study showcases the opportunity and how the ResultsPositive team can help your organization protect application and achieve compliance.
Presentation on 'Effective partnerships: An example in water capacity development' by Kees Leendertse, Cap-Net at 2014 UN-Water Annual International Zaragoza Conference. Preparing for World Water Day 2014: Partnerships for improving water and energy access, efficiency and sustainability. 13-16 January 2014
This is a presentation made at the Asian eHealth Professionals Network by Rajendra Pratap Gupta on the Innovation Working Group Asia which he co-chairs.
Steve Haggblade
POLICY SEMINAR
What Drives Policy Change? Insights from the Kaleidoscope Model of Food Security Policy
Organized by IFPRI, Michigan State University and University of Pretoria, Consortium partners- Food Security Policy Innovation Lab
Slides used for UKGovCamp '14 - to stimulate debate around experiences of using different digital tools to engage (inform, consult and collaborate) with stakeholders
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...patvocates
Patient Advocates in Cancer Research: European Patients’ Perspective, presented by Jan Geissler (Twitter @jangeissler) at ISOQOL 19th Annual Conference, Budapast, 26 Oct 2012
The UK is at the forefront of the global pharmaceutical industry. As well as developing new medicines for many diseases, the pharmaceutical industry in the UK provides many other benefits to the British economy, including income, employment, expertise and major investment.
Smuggling Multi-Cloud Support into Cloud-native Applications using Elastic Co...Nane Kratzke
Elastic container platforms (like Kubernetes, Docker Swarm, Apache Mesos) fit very well with existing cloud-native application architecture approaches. So it is more than astonishing, that these already existing and open source available elastic platforms are not considered more consequently for multi-cloud approaches. Elastic container platforms provide inherent multi-cloud support that can be easily accessed. We present a solution proposal of a control process which is able to scale (and migrate as a side effect) elastic container platforms across different public and private cloud-service providers. This control loop can be used in an execution phase of self-adaptive auto-scaling MAPE loops (monitoring, analysis, planning, execution). Additionally, we present several lessons learned from our prototype implementation which might be of general interest for researchers and practitioners. For instance, to describe only the intended state of an elastic platform and let a single control process take care to reach this intended state is far less complex than to define plenty of specific and necessary multi-cloud aware workflows to deploy, migrate, terminate, scale up and scale down elastic platforms or applications.
Fostering a Startup and Innovation EcosystemTechstars
We are on a mission to make the world a more innovative and prosperous place, one community at a time.
We believe that entrepreneurs are critical to driving a strong global economy and a better world. We do our part by supporting the grassroots leaders who are at the core of every strong entrepreneurial community
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
PE Global Landscape - Mapping & Networking Tool by PFMD.orgThe Synergist.org
The PFMD mapping tool is a dynamic user-populated platform that categorizes and ‘maps’ existing initiatives and frameworks to provide snapshot views of the patient engagement landscape through different stakeholder perspectives.
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
Tripartite dimension of interaction of patients, regulators and industry, presented by Jan Geissler as a scene-setting presentation at the EUPATI Workshop on the interaction of patients, regulators and industry on 20 July 2016 in Berlin
Shift Health co-hosted a Product Development Boot Camp with the Global HIV Vaccine Enterprise. The Boot Camp afforded workshop participants an opportunity to discuss best practices, to learn from the experience of other experts and to create an enduring resource and toolkit that will serve the HIV vaccine field and beyond.
Product development refers to the multifaceted, long-term, highly regulated process that brings promising new drugs, vaccines and medical devices to the populations who most need them. In fields such as HIV vaccine development, where the absence of commercial incentives can make it difficult for companies to lead this process on their own, inventors need to work in partnership with diverse stakeholders and funders to maximize the social and economic impact of their research.
Ryan Wiley, PhD, President at Shift Health, delivered an overview of product development partnerships, which exhibit three common elements:
Defined governance mechanisms that enable appropriate participation in decision-making
Disciplined approach to communication among partners and with stakeholders
IP policies that balance the needs of individual partners with the objectives of the partnership.
Personal Connected Health Alliance StrategyPCHA2016
Discover the new 5 year strategy of the Personal Connected Health Alliance (PCHA) to achieve personal health and wellness for everyone. Visit pchalliance.org for more information about PCHA.
Join us at the Connected Health Conference in Washington D.C. on December 11-14, 2016. For more information, visit www.pchaconference.org.
Personal connected health is currently characterized by limited thought leadership, insufficient coordination and collaboration, and a lack of awareness and understanding of the full potential by all stakeholders: public, providers, policymakers, industry and patients. The Personal Connected Health Alliance is defining the the field of personal connected health to inspire market and policy innovation, research and collective action for sustained adoption of personal connected health technology. The vision is better health and well being for all through increased personal responsibilities and connectivity as well as improved care delivery enabled by technology.
Personal Connected Health Alliance StrategyMary Sheridan
Discover the new 5 year strategy of the Personal Connected Health Alliance (PCHA) to achieve personal health and wellness for everyone. Visit pchalliance.org for more information about PCHA.
Join us at the Connected Health Conference in Washington D.C. on December 11-14, 2016. For more information, visit www.pchaconference.org.
Best Practices in Patient Advocacy Groups Collaboration and Relationship Mana...Best Practices
The current structure of medical education emphasizes pedagogy related to the physician-patient relationship, and thus advocacy opportunities at this level. Patient and professional Advocacy Groups are important to the process of educating the marketplace on new therapies. Strong relationships with advocacy groups are important for educating the public on socially-sensitive conditions and treatment options.
Best Practices, LLC's study identifies effective practices in patient advocacy group collaboration and relationship management. This study also examines ideal structures and skill sets for pharma groups that deal with advocacy groups and emerging trends and challenges in patient advocacy.
Download Full Report: http://bit.ly/2evZ0AE
Partnerships in Health Innovation: Expanding Paradigms of Private Profit and ...Shift Health
Public-private partnerships (P3s) have become an increasingly pivotal—almost doctrinal—driver of R&D across the health sciences. But for all the advantages that have made P3s increasingly inevitable, these partnerships have not become less complex.
When developing a business strategy centered on the patient, organizations must adapt and implement programs that foster information sharing and collaboration while providing faster and greater access to life-changing products.
EUPATI guidances for interaction between Patient organisations and other stak...EUPATI
David Haerry
Increasing patient involvment
EUPATI guidances for interaction between Patient organisations and other stakeholders in medicines development
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
18. About PFMD
18
Goal is to advance a consistent
approach to meaningful patient engagement,
through co-creation and implementation of an efficient,
measurable and reliable meta-framework that integrates the
voice of the patient across the medicines lifecycle.
Established in October 2015
as an open, independent global coalition of stakeholders
managed by a not-for-profit organization.
•“Co-creation” is about encouraging fair and open participation and quality input based on experience and personal insights of
all stakeholders (researchers, clinical developers, regulators, healthcare professionals and patients) to ensure we deliver
significant and desired outcomes where the voice of each stakeholder is equally embedded in final outputs”
19.
20. Putting it all together
Meta-framework co-creation and implementation
21.
22. Understanding the landscape
PFMD Mapping and Networking Tool
Enter your initiatives and find partners
https://involvement-mapping.patientfocusedmedicine.org/
22
Searchable and interactive
repository
Detailed reports of initiatives Internal reports
24. (Pre) Discovery
Phase
Early development
Explore literature
Existing PE Initiatives
Frameworks
Clinical
Development Phase
I – III
Explore literature
Existing PE Initiatives
Frameworks
(Post) Marketing
Phase
Launch / lifecycle
Explore literature
Existing PE Initiatives
Frameworks
Integrate and streamline
Defining key criteria for patient engagement
3 Task Forces to Co-Create a PE Meta-Framework
Defining key criteria for PE
ACTION PLAN